{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:50:25Z","timestamp":1793155825981,"version":"4.5.0"},"reference-count":39,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatology"],"abstract":"<jats:p>Introduction: Brodalumab, a human monoclonal antibody that selectively inhibits the interleukin (IL)-17 receptor subunit A, has been approved for the treatment of moderate-to-severe plaque psoriasis. The treatment benefit of brodalumab has been clearly demonstrated in multiple clinical studies. However, data on effectiveness for difficult-to-treat body regions, especially in everyday clinical practice, are still limited. Methods: In this exploratory observational clinical study, psoriasis patients suffering from nail and scalp involvement who received brodalumab during routine clinical care were enrolled at 7 centers in Germany. Patients were observed for over 60 weeks. The co-primary endpoints were 75% improvement in Psoriasis Scalp Severity Index (PSSI75) at week 12 and 75% improvement in Nail Psoriasis Severity Index (NAPSI75) at week 24. Secondary endpoints included assessment of general skin and disease outcomes, quality-of-life, and patient satisfaction with treatment. Results: Eighty-seven patients were included. Mean age was 46.8 years, 70.1% patients were male, and mean body mass index was 28.9 kg\/m2. The co-primary endpoints were achieved by more than 90% of patients who met criteria for effectiveness analyses (n = 62): 93.6% of patients achieved PSSI75 at week 12 and 90.3% of patients achieved NAPSI75 at week 24. Median body surface area involvement improved from 14% at baseline to 1.5% and 1% at weeks 12 and 24, respectively. Median Dermatology Life Quality Index scores improved from 16 at baseline to 2 and 1 at weeks 12 and 24, respectively. Improvements were maintained in the majority of patients throughout the 60-week study. Brodalumab was well tolerated and patients were highly satisfied with the treatment. Conclusion: Outcomes assessed in this study, including assessments of scalp and nail symptoms, improved following initiation of brodalumab therapy. This study of psoriasis patients in a real-world setting supports the long-term clinical effectiveness of brodalumab on difficult-to-treat body regions. <\/jats:p>","DOI":"10.1159\/000542348","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T17:00:35Z","timestamp":1730912435000},"page":"1-12","source":"Crossref","is-referenced-by-count":2,"title":["Brodalumab Is Effective for Psoriasis Patients with Difficult-To-Treat Body Regions: Results from an Observational Clinical Study"],"prefix":"10.1159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-3739","authenticated-orcid":false,"given":"Stephanie","family":"Dauth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-3204","authenticated-orcid":false,"given":"Ann Christina","family":"Foldenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-2918","authenticated-orcid":false,"given":"Konstantin","family":"Hallmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-3527","authenticated-orcid":false,"given":"Christina","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9969-2315","authenticated-orcid":false,"given":"Anke","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2256-1637","authenticated-orcid":false,"given":"Isabel","family":"Haferland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"M\u00f6ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-5574","authenticated-orcid":false,"given":"Michaela","family":"Koehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-1502","authenticated-orcid":false,"given":"Andreas","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052935"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14433"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1203475416651605"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.12.8576"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109017"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011535.pub6"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0634-8"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.095"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1303a245"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/life12122050"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000504841"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12054"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03197.x"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.10.026"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1185523"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00746-6"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1749546"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17351"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1159\/000051731"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1067\/s0190-9622(03)00910-1"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb04952.x"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.865009"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04411.x"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1087-0024.2004.09113.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.03.026"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-020-00099-7"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S423234"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/1793535"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14130"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.4202"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00521-z"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00523-x"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0364"}],"container-title":["Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/karger.com\/drm\/article-pdf\/doi\/10.1159\/000542348\/4309483\/000542348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/drm\/article-pdf\/doi\/10.1159\/000542348\/4309483\/000542348.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:58:54Z","timestamp":1745420334000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000542348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1159\/000542348","archive":["Portico"],"relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.6084\/m9.figshare.27503358","asserted-by":"subject"}]},"ISSN":["1018-8665","1421-9832"],"issn-type":[{"value":"1018-8665","type":"print"},{"value":"1421-9832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]}}}